Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biomarkers for Prediction of Analgesic Efficacy in Knee OA
NCT05256342Completed
- Sponsor
- Rambam Health Care Campus
- Start
- Dec 2021
- Primary completion
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial in knee osteoarthritis (OA) comparing Duloxetine with Etoricoxib (2 arms). Primary endpoints: Conditioned Pain Modulation up to 2 years, Temporal Summation up to 2 years and 4 more. Started Dec 2021; status: completed.
02
Drugs
duloxetineetoricoxib
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT05256342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05256342.